{"id":"W1975200147","doi":"10.1111/j.1533-869x.2003.01099.x","title":"Combining doxorubicin and liposomal anti‐HER‐2/NEU antisense oligodeoxynucleotides to treat HER‐2/NEU‐expressing MDA‐MB‐435 breast tumor model","year":2003,"lang":"en","type":"article","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Celator Pharmaceuticals (Canada); University of British Columbia","funders":"","keywords":"HER2/neu; Liposome; Doxorubicin; Cancer research; Pharmacology; Breast tumor; Medicine; Biology; Breast cancer; Internal medicine; Chemotherapy; Cancer; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001640977,0.0003839364,0.0004425936,0.0001813569,0.00007278163,0.0001874146,0.0001645943,0.0002639196,0.0004349868],"category_scores_gemma":[0.0000662379,0.0001353886,0.0001861599,0.0001091921,0.0001141433,0.0002102156,0.0001231134,0.0003776559,0.0001391127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002037772,"about_ca_system_score_gemma":0.0002486835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008100905,"about_ca_topic_score_gemma":0.001931723,"domain_scores_codex":[0.9999182,0.00001209915,0.000006463998,0.00002212804,0.00001982493,0.00002128256],"domain_scores_gemma":[0.9999641,0.000006019378,0.000008708512,0.000003314131,0.000005707572,0.00001216027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001356067,0.00008558768,0.00007425314,0.00004434834,0.000008126878,0.00002113627,0.000009734451,0.0001334421,0.9974584,0.00004542373,0.00002853596,0.001955589],"study_design_scores_gemma":[0.00009089307,0.004909542,0.001402529,0.000008543897,0.00007125508,0.0001616719,0.00001566697,0.00177344,0.9882767,0.0000299489,0.003249027,0.00001075433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909763,0.00255849,0.005075322,0.0001022938,0.00009975528,0.0001276683,0.0001312712,0.00006837907,0.0008606117],"genre_scores_gemma":[0.9892467,0.002560907,0.005325818,0.00005733308,0.00002947285,0.00011948,0.0002188296,0.00001577952,0.002425739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008100905,"threshold_uncertainty_score":0.001610756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04966820151808032,"score_gpt":0.3680381729148243,"score_spread":0.3183699713967439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}